These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5806158)

  • 1. Effects of ouabain on insulin secretion in the dog.
    Triner L; Papayoanou J; Killian P; Vulliemoz Y; Castany R; Nahas GG
    Circ Res; 1969 Aug; 25(2):119-29. PubMed ID: 5806158
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of ouabain on insulin secretion in the anesthetized dog.
    Lefebvre PJ; Luyckx AS
    Biochem Pharmacol; 1972 Feb; 21(3):339-45. PubMed ID: 5014491
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacological studies of a new highly effective blood sugar decreasing sulfonamide, glibenclamide (HB 419)].
    Loubatières A; Mariani MM; Ribes G; de Malbosc H; Alric R; Chapal J
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1354-63. PubMed ID: 4899083
    [No Abstract]   [Full Text] [Related]  

  • 4. The stimulus-secretion coupling of glucose-induced insulin release. II. Interaction of alkali and alkaline earth cations.
    Malaisse WJ; Malaisse-Lagae F; Brisson G
    Horm Metab Res; 1971 Mar; 3(2):65-70. PubMed ID: 4941847
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mode of action of blood glucose lowering sulfonamides. Other extrapancreatic effects].
    Madsen J
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():415-28. PubMed ID: 4906023
    [No Abstract]   [Full Text] [Related]  

  • 6. [Propranolol and hypoglycemic sulfonamides. Study on insulin secretion and blood sugar].
    Loubathières A; Mariani MM; Ribes G; Chapal J
    C R Seances Soc Biol Fil; 1971; 165(6):1393-7. PubMed ID: 4262051
    [No Abstract]   [Full Text] [Related]  

  • 7. Differences in insulin release in response to glucose and tolbutamide stimulation.
    Bennett LL; Curry DL; Curry K
    Proc Soc Exp Biol Med; 1973 Nov; 144(2):436-9. PubMed ID: 4746913
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of ouabain on insulin secretion in man.
    Saxton C; Majid PA; Clough G; Taylor SH
    Clin Sci; 1972 Jan; 42(1):57-62. PubMed ID: 5008545
    [No Abstract]   [Full Text] [Related]  

  • 9. [Physiological and pharmacological aspects of the central role of the pancreas in the mode of action of hypoglycemic sulfonamides].
    Loubatières A
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():216-55. PubMed ID: 4906020
    [No Abstract]   [Full Text] [Related]  

  • 10. Differences between the effects of adrenaline and noradrenaline on insulin secretion in the dog.
    Ribes G; Blayac JP; Loubatieres-Mariani MM
    Diabetologia; 1983 Feb; 24(2):107-12. PubMed ID: 6341134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proceedings: Inhibitory effect of propranolol on insulin secretion.
    Furman BL; Tayo FM
    Br J Pharmacol; 1973 Sep; 49(1):145P. PubMed ID: 4787526
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of potassium chloride infusion on insulin secretion in vivo.
    Hiatt N; Davidson MB; Bonorris G
    Horm Metab Res; 1972 Mar; 4(2):64-8. PubMed ID: 5028223
    [No Abstract]   [Full Text] [Related]  

  • 13. [The discovery of hypoglycemic sulfonamides and particularly of their action mechanism].
    Loubatières A
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():20-56. PubMed ID: 4906982
    [No Abstract]   [Full Text] [Related]  

  • 14. [In vivo stimulation of insulin secretion by ouabain in dogs].
    Loubatières A; Mariani MM; Savi L; Sorel G
    C R Seances Soc Biol Fil; 1968; 162(8):1589-91. PubMed ID: 4238187
    [No Abstract]   [Full Text] [Related]  

  • 15. Exocrine and endocrine functions of the allografted pancreas.
    Himal HS; Goodhead B; Colle E; MacLean LD
    Can Med Assoc J; 1969 Mar; 100(9):422-7. PubMed ID: 4889665
    [No Abstract]   [Full Text] [Related]  

  • 16. [Recent pharmacologic aspects of sulfamides modifying insulin secretion (hypoglycemic and hyperglycemic sulfamides)].
    Loubatiéres A; Mariani MM
    Actual Physiol Pathol (Paris); 1973; 4():237-66. PubMed ID: 4219256
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
    Loubatières A; Ribes G; Mariani MM; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta-adrenergic stimulation and insulin release in dogs following HB 419.
    Sirek OV; Vigas M; Niki A; Niki H; Sirek A
    Diabetologia; 1969 Aug; 5(4):207-10. PubMed ID: 4902716
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of exogenous bonito insulin on endogenous insulin secretion in dogs.
    Ohgawara H; Tasaka Y; Kosaka K; Shizume K
    Endocrinol Jpn; 1974 Apr; 21(2):147-56. PubMed ID: 4408208
    [No Abstract]   [Full Text] [Related]  

  • 20. Potentiation of the insulinotropic and hypoglycemic action of gliquidone by succinic acid esters.
    García-Martínez JA; Villanueva-Peñacarrillo ML; Valverde I; Björkling F; Malaisse WJ
    Eur J Pharmacol; 1997 Apr; 325(1):65-8. PubMed ID: 9151940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.